Background:
Management of pacemaker (PM) infections in patients with an advanced age
is one of the most sensitive issues, since they possess particular
clinical challenges due to higher rates of medical comorbidities. The
novel leadless pacemaker (LP) requiring no transvenous lead or device
pocket, may provide new opportunities for the management of PM
infections among patients with an advanced age.